Usman Baber, MD
Primary Specialty:
Cardiology
Languages Spoken:
English
Gender:
Male
About Usman Baber
Dr. Baber is an Associate Professor of Medicine at the University of Oklahoma Health Sciences Center and serves as the Director of Interventional Cardiology and the Cardiac Catheterization Laboratory. Prior to joining the University of Oklahoma, Dr. Baber served as the Director of Cath Lab Quality and Outcomes Research within the Cardiovascular Institute at Mount Sinai Hospital in New York City. During his fellowship training he also earned a Master’s Degree in biostatistics from the Mailman School of Public Health at Columbia University. From a clinical standpoint Dr. Baber focuses on complex, high-risk coronary interventions. Research interests include clinical and translational projects related to bleeding, thrombosis and platelet function. Most recently Dr. Baber served as the Chair of the Clinical and Data Coordinating Center for the international, randomized TWILIGHT trial, which was published in the NEJM in 2019. He is a frequent lecturer at international cardiology conferences, serves on the Editorial Boards of numerous peer-reviewed journals and teaches clinical trial design and biostatistics for the interventional cardiology board review course sponsored by the American College of Cardiology.
Affiliations
OU Health Physicians – Cardiology, Pulmonary & Vascular Medicine Clinic,
OU Health Physicians Building - Oklahoma City,
OU Health Physicians – Advanced Heart Clinic
Health Education
Medical School
University of Texas Southwestern Medical School
Residency
Parkland Memorial Hospital
Fellowship
Mount Sinai Medical Center
Board Certification
American Board of Internal Medicine
Medical Interests
Areas of Interest:
Acute coronary syndromes Complex, high-risk coronary intervention Low-contrast PCI Outcomes research
